Blanket Purchase Agreement HT941024A0007
- Not listed
- Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the international in vitro diagnostics provider Ortho Clinical Diagnostics, was awarded a single-award Blanket Purchase Agreement by the Defense Health Agency on October 1, 2025, valued at $250,000 with a performance period extending through September 30, 2030. This indefinite delivery vehicle procures laboratory medical supplies for the Medical Department Activity (MEDDAC) in Japan, with all work performed in-country on a firm...
- Ortho Clinical Diagnostics K.K. was awarded a single-award Blanket Purchase Agreement by Pacific Air Forces valued at $2.53 million with a period of performance from April 20, 2021, through April 19, 2026. The contract procures clinical laboratory chemistry and immunoassay testing systems, specifically VITROS reagents and consumable supplies to support diagnostic laboratory operations across U.S. military medical installations in the Indo-Pacific region. The award carries no socioeconomic...
- The Department of the Air Force Pacific Air Forces awarded Ortho Clinical Diagnostics K.K. a single-award blanket purchase agreement with a potential value of $250,000 to provide reagents for clinical laboratory chemistry and immunoassay testing systems. The BPA has a period of performance through June 30, 2022. The original solicitation sought a service provider to supply a chemistry analyzer, related reagents, equipment, and maintenance services to the 374th Medical Group at Yokota Air Base in...
- The Department of the Navy Bureau of Medicine and Surgery awarded an indefinite-delivery contract to Ortho Clinical Diagnostics K.K. to provide VITROS laboratory reagents in support of various medical treatment facilities located in Japan. Task orders issued against the contract procure reagents for clinical laboratory operations and medical research activities at sites including the Naval Medical Research Center in Yokosuka, the Naval Hospital in Atsugi, and the Bureau of Medicine and Surgery...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract valued at $1.25 million to Ortho-Clinical Diagnostics Singapore Pte. LTD. Korea Branch on February 1, 2025, extending through September 30, 2026, for the supply of VITROS XT7600 reagents and consumables. This sole-source procurement was established under Federal Acquisition Regulation 13.501(a)(1)(ii), reflecting the contractor's status as the only viable source capable of meeting the specific technical and...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a single-award indefinite delivery contract by the Defense Health Agency on June 1, 2020, with a ceiling value of $2,655,406.12 and ultimate completion date of September 30, 2024. The contract procures Ortho Vision reagents and consumables to support diagnostic laboratory operations at military treatment facilities, with performance locations primarily in Raritan, New Jersey and South Korea. No set-aside...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Quidelortho Sales Company, LLC (UEI: ZFXRG96JMJ39) on October 1, 2024, with a ceiling value of $771,818.90 and ultimate completion date of September 30, 2029. This contract procures Ortho Clinical Diagnostics reagents and consumables, as well as Ortho Vision reagents, in support of the Brooke Army Medical Center in South Korea. The procurement was issued with no set-aside designation and utilizes firm fixed-price...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $1.2 million to Ortho-Clinical Diagnostics GMBH, effective October 1, 2024, through September 30, 2029, for the procurement of consumables compatible with government-owned Ortho Vision Analyzer diagnostic equipment. Ortho-Clinical Diagnostics GMBH, a Germany-based manufacturer and distributor of diagnostic systems headquartered in Cologne, serves as the prime contractor under this non-set-aside vehicle. The BPA...
- The Defense Health Agency awarded a single-award Indefinite Delivery Contract valued at $2,282,162.15 to Quidelortho Sales Company, LLC (formerly Ortho Clinical Diagnostics, Inc. under Cage Code 1C0L5) for immunoassay testing equipment and related laboratory services. The contract, effective April 1, 2024, through March 30, 2029, was awarded without set-aside designation and involves no socioeconomic preferences. The original procurement, identified as a sole source justification under Federal...
- The U.S. Army Medical Command awarded a single-award Blanket Purchase Agreement valued at $2,000,000 to Ortho-Clinical Diagnostics GMBH on August 27, 2020, for the provision of medical supplies compatible with Ortho Vitros analyzers. The agreement, which carried an ultimate completion date of August 26, 2025, was issued with no set-aside designation and represents a firm fixed price procurement vehicle designed to support the Army's decentralized diagnostic capabilities across its healthcare...
- HT941024A0007Blanket Purchase Agreement
- 22Federal Contract Awards
The Defense Health Agency awarded a single-award Blanket Purchase Agreement valued at $2.875 million to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of Ortho Clinical Diagnostics, effective from July 1, 2024, through June 30, 2029. The contract procures Chemistry and Immunoassay Testing System reagents and consumable supplies, specifically VITROS 7600 laboratory testing equipment consumables, for use at Yokota Air Base and other U.S. military medical facilities throughout Japan. The agreement was not issued under any socioeconomic set-aside program and contemplates performance entirely within Japan. Ortho Clinical Diagnostics K.K. has maintained an established supply relationship with the Defense Health Agency and Department of Navy Bureau of Medicine and Surgery, providing critical laboratory diagnostic materials to multiple naval hospitals and military medical treatment facilities across the Indo-Pacific region, including installations in Yokosuka, Atsugi, Sasebo, and Iwakuni. Through the initial period of performance documented herein, the Defense Health Agency has exercised multiple delivery orders under this blanket purchase agreement, totaling approximately $524,130 as of September 2025. These task orders, ranging from approximately $800 to $69,648 in individual value and executed on a firm fixed-price basis, support ongoing laboratory diagnostic operations and clinical testing services for active duty military personnel, dependents, and retirees. The delivery orders demonstrate consistent procurement of VITROS chemistry and immunoassay testing system reagents and supplies on a quarterly and monthly basis, reflecting the routine consumable replenishment requirements of military clinical laboratories. The contract structure enables the Defense Health Agency to maintain uninterrupted access to these essential laboratory diagnostic supplies while leveraging the vendor's specialized expertise in supplying sophisticated in vitro diagnostic testing systems to U.S. military healthcare operations in the region.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Supplemental Agreement for work within scope | $0 | 6/27/25 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 5/7/25 | |
| P00004 | Other Administrative Action | $0 | 2/25/25 | |
| P00003 | Other Administrative Action | $0 | 1/17/25 | |
| P00002 | Other Administrative Action | $0 | 10/17/24 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call HT941024A0007-HT941025FE047 | Ortho Clinical Diagnostics K.K. | $50.9k | 9/23/25 | 10/24/25 | 9/23/25 | |
BPA Call HT941024A0007-HT941026FE004 | Ortho Clinical Diagnostics K.K. | $18.1k | 11/17/25 | 11/11/25 | 12/11/25 | |
BPA Call HT941024A0007-HT941026FE011 | Ortho Clinical Diagnostics K.K. | $11.5k | 12/15/25 | 12/19/25 | 12/14/25 | |
BPA Call HT941024A0007-HT941026FE007 | Ortho Clinical Diagnostics K.K. | $50.1k | 11/5/25 | 11/17/25 | 12/3/25 | |
BPA Call HT941024A0007-HT941026FE015 | Ortho Clinical Diagnostics K.K. | $13.8k | 1/6/26 | 1/16/26 | 1/5/26 |